# Suzhou Rainmed Medical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-rainmed-medical-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.rainmed.com
- Total disclosed funding: $115M
- Latest round: Series D (Dec 1, 2021)
- Investors on record: 5

## About

Established in 2016 and based in Suzhou, China, Suzhou Rainmed Medical Technology Co., Ltd. operates as a cardiovascular disease medical device manufacturer that provides cardiovascular disease medical device. Mr. Yonghui Lv, the CEO of the company, once served as deputy general manager of Lepu Medical Technology (Beijing) Co., Ltd.  In 2015, the company built an animal laboratory. In 2022, it was listed on the Hong Kong Stock Exchange. Its stock code is 2297.

The company provides cardiovascular disease medical device. The company obtained China’s NMPA marketing approval and EU CE certification. The business of the company includes the design, development and commercialization of coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microcirculatory resistance (caIMR) systems. The company's product includes FlashAngio caFFR System and FlashAngio caIMR System. The company will promote vascular intervention surgery machine in the next 3 years.

## Funding rounds

- Series D, Dec 1, 2021, $100M — Ping An Trust, Serica Partners Asia, Lighthouse Canton
- Series C, Mar 8, 2021, $15M — Greenwoods Asset Management, Cowin Capital

## Investors

- Greenwoods Asset Management (https://capitalatlas.ai/funds/greenwoods-asset-management) — Series C
- Cowin Capital (https://capitalatlas.ai/funds/cowin-capital) — Series C
- Ping An Trust — Series D
- Serica Partners Asia — Series D
- Lighthouse Canton (https://capitalatlas.ai/funds/lighthouse-canton) — Series D